Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Ajanta Pharma Ltd.
Source DateBoard Meeting DateDetails
17-Oct-2024 28-Oct-2024 Quarterly Results
18-Jul-2024 30-Jul-2024 Quarterly Results
22-Apr-2024 02-May-2024 Buy Back of Shares & Quarterly Results & Audited Results
19-Jan-2024 31-Jan-2024 Second Interim Dividend & Quarterly Results
19-Oct-2023 31-Oct-2023 Quarterly Results
24-Jul-2023 27-Jul-2023 Interim Dividend & Quarterly Results
14-Jul-2023 27-Jul-2023 Quarterly Results
27-Apr-2023 05-May-2023 Audited Results
06-Mar-2023 10-Mar-2023 Buy Back of Shares
23-Jan-2023 01-Feb-2023 Quarterly Results
21-Oct-2022 03-Nov-2022 Quarterly Results & Interim Dividend
20-Jul-2022 28-Jul-2022 Quarterly Results
02-May-2022 10-May-2022 Bonus issue & Audited Results
21-Jan-2022 31-Jan-2022 Quarterly Results
23-Dec-2021 28-Dec-2021 Buy Back of Shares
21-Oct-2021 29-Oct-2021 Interim Dividend & Quarterly Results
22-Jul-2021 29-Jul-2021 Quarterly Results
22-Apr-2021 30-Apr-2021 Audited Results
25-Jan-2021 02-Feb-2021 Quarterly Results
23-Oct-2020 03-Nov-2020 Buy Back of Shares & Quarterly Results & Interim Dividend
Page 1 of 5
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.